Skip to main content
Displaying 13 - 24 of 32
Display:
12
24
48
Liver Tumours
Interventional therapy for HCC: how to optimize patient selection and improve clinical outcomes
Webcasts
View
Liver Tumours
Conclusion and Q&A
Webcasts
View
Liver Tumours
Introduction
Webcasts
View
Liver Tumours
Bayer: Evolving horizons in HCC diagnosis and therapy (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
CymaBay Therapeutics: "Resetting the ideal goals of PBC treatment: A case – based discussion" (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Introduction
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Case Based Discussion on Biochemical Normalization
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Case Based Discussion on QOL/Pruritus
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Conclusion
Webcasts
View
Liver Tumours
Introduction
Webcasts
View
Liver Tumours
General Overview on liver imaging, when do we need MRI? Benefits of liver-specific agents
Webcasts
View
Liver Tumours
Imaging of HCC, results of the SORAMIC trial and treatment stratification in HCC
Webcasts
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Current page
2
Page
3
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy